Related Experiment Videos

Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells

L M Mooney1, K A Al-Sakkaf, B L Brown

  • 1Institute for Cancer Studies, Division of Genomic Medicine, Medical School, University of Sheffield, Sheffield S10 2RX, UK.

British Journal of Cancer
|October 10, 2002
PubMed

Insights

This study reveals distinct apoptosis pathways in breast cancer cells. MCF-7 and T47D cells exhibit differential caspase activation and mitochondrial changes during staurosporine-induced cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Apoptosis is crucial for cancer treatment.
  • Understanding apoptosis mechanisms in breast cancer is vital.

Purpose of the Study:

  • Investigate apoptosis mechanisms in MCF-7 and T47D breast cancer cells.
  • Characterize the role of caspases and mitochondrial pathways in staurosporine-induced apoptosis.

Main Methods:

  • Utilized staurosporine as an apoptotic stimulus.
  • Analyzed DNA fragmentation, caspase activity (DEVDase), pro-caspase cleavage, PARP cleavage, cytochrome c release, mitochondrial membrane potential, and Bax translocation.
  • Employed z-VAD-fmk to assess caspase dependency.

Main Results:

  • Staurosporine induced dose- and time-dependent DNA fragmentation, abrogated by z-VAD-fmk.
  • MCF-7 cells showed caspase-3-independent DNA fragmentation and pro-caspase-6 cleavage, unlike T47D cells.
  • Differential kinetics of PARP cleavage, cytochrome c release, and Bax translocation were observed between cell lines.
  • Caspase-independent reduction in mitochondrial transmembrane potential occurred post-cytochrome c release.

Conclusions:

  • Apoptotic events in MCF-7 and T47D cells differ temporally.
  • Distinct caspase activation profiles and mitochondrial changes characterize apoptosis in these breast cancer cell lines.
  • Bax translocation to mitochondria precedes cytochrome c release in both cell types.

Related Concept Videos